A capability deck for a pharmaceutical manufacturer: what to show, and what to leave to the visit

A capability deck can lose the room by slide eleven, when the buyer stops looking at the screen (the meeting below is an invented example). A deck for a pharmaceutical manufacturer has one job: to move the buyer from the first meeting to the documents stage and a visit. So it should introduce the site, the dosage forms, the lines and the people, and stop.

Licences, batch records and validation detail belong in documents the buyer requests, shared under a confidentiality agreement where needed. A deck that tries to be the dossier gets skimmed and forwarded to people you never meant to reach.

A meeting told minute by minute

Imagine, as an invented example, an oral solids and sachet plant at Sangareddy, outside Hyderabad. A founder from Kochi, launching a nutrition range, has fifty minutes booked. The plant's deck has forty slides. It opens with the founder's journey and a map of India with the plant marked on it. Its approvals slide shows five logos, one of which belongs to a sister unit.

In the first ten minutes the deck covers the company's history. The buyer's own quality adviser has a pen and has not yet written anything. At twenty minutes the slides reach equipment lists by make. At thirty-five the buyer's team finally sees the sachet line, in a stock photograph of a different machine. Then the adviser spots the sister unit's logo and asks which approvals the plant holds in its own name. The room goes quiet. The meeting ends with an email asking for documents, and no visit date. The founder's two days of travel and the plant's morning are lost.

Nothing in that deck was false. It answered no question in the order the buyer asked it.

The buyer's questions, in the order they come

Build the deck around these, one slide each, not around the company's history.

1. Where is the plant and what is it called? One slide. Name, place, year started, one line on what you make.
2. Which forms do you make, and in what packs? Real photographs of your products and pack formats.
3. How big are you, honestly? Lines by form, and the batch sizes you actually run. Not the nameplate figure of every machine added together.
4. Who runs quality? The QA head's name, photograph and number, and what is tested in-house.
5. What approvals do you hold? Named exactly as your adviser words them, in the plant's own name only.
6. Can you help me develop the product? What your formulation team does and what it does not.
7. How does a project run? Enquiry, documents, visit, trial batch, agreement, first dispatch, with no dates promised.
8. What next? A suggested step: a call between the QA heads, the questionnaire, or a visit date.

Eight to twelve slides cover this with room for a map and a markets slide. If you have more, ask of each one what the buyer would decide differently without it.

The keep, move or drop test

For every slide in an existing deck ask three questions in turn, and stop at the first yes.

Does it prove a claim the buyer cannot check from the plant's own documents? Then it is a document, so move it to the set sent on request. This catches scanned licences, certificates, equipment lists and stability data.

Does it name a client or a sister unit? Drop it unless you have written permission, or the unit is the plant being sold. A buyer who sees another brand named without consent wonders whether you will name theirs.

Would the meeting be poorer without it? If yes, keep it. If you hesitate, drop it.

Approvals are where the test bites hardest. Which approvals apply to which products and markets, and how they may be described in sales material, differ by authority and change over time. Check slide five with your own adviser or the regulator before the deck goes out.

Two decks from one outline

A presented deck is sparse: photographs, short headings and very little text, because you are in the room to explain it. A sent deck has to explain itself for people who never met you, so it gets two or three plain lines under each slide and your contact details on every page. Keep the sent file small enough to open on a phone, since a heavy file forwarded over WhatsApp tends to be abandoned.

For a distributor rather than a brand owner, swap the development slide for your own range, pack sizes and supply terms, and name each file clearly so the wrong one does not go out.

The same meeting, rebuilt

The Sangareddy plant cut to ten slides on the order above. The sister unit's logo went. The approvals slide named only what the plant holds in its own name, in the words its adviser gave, with a line saying copies follow on request. A real photograph of the sachet line replaced the stock one. The QA head's face and number went on slide four.

At the next meeting the Kochi buyer's adviser was writing by slide four. Capacity and batch size had arrived. The founder asked about sachet film suppliers, the kind of question a buyer asks when already picturing the product running. The meeting ended with a date for the visit and a list of papers to follow under the agreement. The rebuilt deck took the owner's team two weekends, and the founder still chose to start with one product, not the full range.

When a deck is the wrong tool

Tender and institutional buyers want their own forms filled, not a presentation, and a deck suggests you have not read the tender. A repeat client adding a product needs the specific answer, nothing more. And if the plant is not ready to be visited, hold the deck back: a visit date you have to postpone does more harm than no deck.

Cut your own deck tonight

Open your deck beside the eight questions. Run the keep, move or drop test on every slide. Move licence copies and equipment lists into a document set, check the approvals slide with your adviser, and put your QA head in. The pharmaceutical manufacturing hub shows where a deck sits in a buyer's decision. If you want help with the deck, through capability presentations, or with the document set, tell us what you need.